nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—CYP3A7—Simvastatin—atherosclerosis	0.0499	0.0575	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0499	0.0575	CbGbCtD
Cisapride—CYP3A7—Lovastatin—atherosclerosis	0.0488	0.0563	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0488	0.0563	CbGbCtD
Cisapride—CYP2B6—Simvastatin—atherosclerosis	0.0475	0.0548	CbGbCtD
Cisapride—CYP3A5—Rosuvastatin—atherosclerosis	0.0403	0.0464	CbGbCtD
Cisapride—CYP3A5—Simvastatin—atherosclerosis	0.0374	0.0432	CbGbCtD
Cisapride—CYP3A5—Pravastatin—atherosclerosis	0.0366	0.0422	CbGbCtD
Cisapride—CYP3A5—Lovastatin—atherosclerosis	0.0366	0.0422	CbGbCtD
Cisapride—CYP2C8—Simvastatin—atherosclerosis	0.036	0.0415	CbGbCtD
Cisapride—CYP2C8—Pravastatin—atherosclerosis	0.0352	0.0406	CbGbCtD
Cisapride—CYP2C8—Lovastatin—atherosclerosis	0.0352	0.0406	CbGbCtD
Cisapride—CYP2C19—Rosuvastatin—atherosclerosis	0.0325	0.0374	CbGbCtD
Cisapride—CYP2C19—Simvastatin—atherosclerosis	0.0302	0.0348	CbGbCtD
Cisapride—CYP2C19—Lovastatin—atherosclerosis	0.0296	0.0341	CbGbCtD
Cisapride—CYP2D6—Niacin—atherosclerosis	0.029	0.0335	CbGbCtD
Cisapride—CYP2C9—Rosuvastatin—atherosclerosis	0.027	0.0311	CbGbCtD
Cisapride—CYP2C9—Simvastatin—atherosclerosis	0.0251	0.0289	CbGbCtD
Cisapride—CYP2C9—Pravastatin—atherosclerosis	0.0246	0.0283	CbGbCtD
Cisapride—CYP2C9—Lovastatin—atherosclerosis	0.0246	0.0283	CbGbCtD
Cisapride—CYP2D6—Simvastatin—atherosclerosis	0.023	0.0265	CbGbCtD
Cisapride—CYP2D6—Pravastatin—atherosclerosis	0.0225	0.0259	CbGbCtD
Cisapride—CYP2D6—Lovastatin—atherosclerosis	0.0225	0.0259	CbGbCtD
Cisapride—CYP3A4—Rosuvastatin—atherosclerosis	0.0157	0.0181	CbGbCtD
Cisapride—CYP3A4—Ezetimibe—atherosclerosis	0.0157	0.0181	CbGbCtD
Cisapride—CYP3A4—Simvastatin—atherosclerosis	0.0146	0.0168	CbGbCtD
Cisapride—CYP3A4—Pravastatin—atherosclerosis	0.0143	0.0165	CbGbCtD
Cisapride—CYP3A4—Lovastatin—atherosclerosis	0.0143	0.0165	CbGbCtD
Cisapride—Iloperidone—HRH1—atherosclerosis	0.00224	0.857	CrCbGaD
Cisapride—HTR2A—arteriole—atherosclerosis	0.00141	0.197	CbGeAlD
Cisapride—HTR2A—vein—atherosclerosis	0.000839	0.117	CbGeAlD
Cisapride—HTR2A—hindlimb—atherosclerosis	0.000557	0.078	CbGeAlD
Cisapride—HTR2A—appendage—atherosclerosis	0.000478	0.0669	CbGeAlD
Cisapride—Gefitinib—ALB—atherosclerosis	0.000372	0.143	CrCbGaD
Cisapride—HTR2A—artery—atherosclerosis	0.000342	0.0478	CbGeAlD
Cisapride—HTR2A—endothelium—atherosclerosis	0.000289	0.0404	CbGeAlD
Cisapride—HTR2A—blood vessel—atherosclerosis	0.000266	0.0372	CbGeAlD
Cisapride—CYP3A7—liver—atherosclerosis	0.000257	0.036	CbGeAlD
Cisapride—CYP2A6—adipose tissue—atherosclerosis	0.000255	0.0357	CbGeAlD
Cisapride—HTR2B—cardiovascular system—atherosclerosis	0.000222	0.0311	CbGeAlD
Cisapride—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000219	0.0306	CbGeAlD
Cisapride—HTR2B—adipose tissue—atherosclerosis	0.000196	0.0274	CbGeAlD
Cisapride—CYP2A6—liver—atherosclerosis	0.000179	0.025	CbGeAlD
Cisapride—KCNH2—cardiovascular system—atherosclerosis	0.000177	0.0248	CbGeAlD
Cisapride—CYP2B6—cardiovascular system—atherosclerosis	0.000146	0.0204	CbGeAlD
Cisapride—CYP2C9—cardiovascular system—atherosclerosis	0.000144	0.0202	CbGeAlD
Cisapride—HTR2A—connective tissue—atherosclerosis	0.000136	0.0191	CbGeAlD
Cisapride—CYP3A5—adipose tissue—atherosclerosis	0.000129	0.0181	CbGeAlD
Cisapride—HTR2A—cardiovascular system—atherosclerosis	0.000119	0.0166	CbGeAlD
Cisapride—CYP2C19—liver—atherosclerosis	0.000115	0.0161	CbGeAlD
Cisapride—CYP2C8—liver—atherosclerosis	0.0001	0.014	CbGeAlD
Cisapride—CYP1A2—liver—atherosclerosis	9.39e-05	0.0131	CbGeAlD
Cisapride—CYP3A5—liver—atherosclerosis	9.06e-05	0.0127	CbGeAlD
Cisapride—CYP2B6—liver—atherosclerosis	9e-05	0.0126	CbGeAlD
Cisapride—CYP2C9—liver—atherosclerosis	8.92e-05	0.0125	CbGeAlD
Cisapride—HTR2A—liver—atherosclerosis	7.34e-05	0.0103	CbGeAlD
Cisapride—CYP3A4—liver—atherosclerosis	6.8e-05	0.00951	CbGeAlD
Cisapride—CYP2D6—liver—atherosclerosis	6.69e-05	0.00936	CbGeAlD
Cisapride—CYP2D6—Metabolism—ABCA1—atherosclerosis	8.66e-06	7.04e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PPARA—atherosclerosis	8.63e-06	7.02e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—MTHFR—atherosclerosis	8.6e-06	7e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—NOS3—atherosclerosis	8.59e-06	6.99e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ABCA1—atherosclerosis	8.58e-06	6.98e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PDGFB—atherosclerosis	8.53e-06	6.94e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.48e-06	6.9e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.45e-06	6.88e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PPARA—atherosclerosis	8.44e-06	6.87e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GSTM1—atherosclerosis	8.43e-06	6.86e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PDGFB—atherosclerosis	8.39e-06	6.83e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—AGT—atherosclerosis	8.36e-06	6.8e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CG—atherosclerosis	8.35e-06	6.79e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—AGT—atherosclerosis	8.33e-06	6.78e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—NOS3—atherosclerosis	8.3e-06	6.75e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—LPL—atherosclerosis	8.27e-06	6.73e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—HMGCR—atherosclerosis	8.23e-06	6.69e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AGT—atherosclerosis	8.2e-06	6.67e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—APOE—atherosclerosis	8.19e-06	6.67e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—AGT—atherosclerosis	8.17e-06	6.65e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.16e-06	6.64e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—LEP—atherosclerosis	8.16e-06	6.64e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—APOE—atherosclerosis	8.16e-06	6.64e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CAV1—atherosclerosis	8.12e-06	6.6e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—APOA1—atherosclerosis	8.1e-06	6.59e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CAV1—atherosclerosis	8.09e-06	6.58e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—HMOX1—atherosclerosis	8.07e-06	6.57e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GPX1—atherosclerosis	8.07e-06	6.57e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—APOA1—atherosclerosis	8.07e-06	6.57e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—LEP—atherosclerosis	8.03e-06	6.53e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—APOE—atherosclerosis	8.03e-06	6.53e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—APOE—atherosclerosis	8.01e-06	6.52e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—MAPK3—atherosclerosis	7.99e-06	6.5e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CAV1—atherosclerosis	7.96e-06	6.47e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—ALB—atherosclerosis	7.95e-06	6.47e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—APOA1—atherosclerosis	7.94e-06	6.46e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CAV1—atherosclerosis	7.93e-06	6.46e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—APOA1—atherosclerosis	7.91e-06	6.44e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—INS—atherosclerosis	7.9e-06	6.43e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CD36—atherosclerosis	7.86e-06	6.4e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ESR1—atherosclerosis	7.79e-06	6.34e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CCL2—atherosclerosis	7.77e-06	6.33e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—APOB—atherosclerosis	7.73e-06	6.29e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—F2—atherosclerosis	7.7e-06	6.26e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ESR1—atherosclerosis	7.67e-06	6.24e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IGF1—atherosclerosis	7.64e-06	6.22e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CXCL8—atherosclerosis	7.62e-06	6.2e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—NOS3—atherosclerosis	7.61e-06	6.19e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTGS2—atherosclerosis	7.59e-06	6.18e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—F2—atherosclerosis	7.57e-06	6.16e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GSTM1—atherosclerosis	7.52e-06	6.12e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—MTHFR—atherosclerosis	7.45e-06	6.06e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—HMOX1—atherosclerosis	7.43e-06	6.04e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.42e-06	6.04e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CG—atherosclerosis	7.39e-06	6.02e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—LPL—atherosclerosis	7.38e-06	6.01e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	7.36e-06	5.99e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—HMOX1—atherosclerosis	7.36e-06	5.99e-05	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—AKT1—atherosclerosis	7.36e-06	5.99e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ABCA1—atherosclerosis	7.33e-06	5.97e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.32e-06	5.96e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PPARA—atherosclerosis	7.31e-06	5.95e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—LIPC—atherosclerosis	7.28e-06	5.92e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SERPINE1—atherosclerosis	7.26e-06	5.9e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	7.25e-06	5.9e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—IL6—atherosclerosis	7.24e-06	5.89e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—APOC3—atherosclerosis	7.23e-06	5.88e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CG—atherosclerosis	7.23e-06	5.88e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GPX1—atherosclerosis	7.2e-06	5.86e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—LDLR—atherosclerosis	7.19e-06	5.85e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PPARG—atherosclerosis	7.13e-06	5.81e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—APOB—atherosclerosis	7.11e-06	5.79e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AGT—atherosclerosis	7.08e-06	5.76e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	7.05e-06	5.74e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—APOB—atherosclerosis	7.05e-06	5.74e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CETP—atherosclerosis	7.02e-06	5.71e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CD36—atherosclerosis	7.02e-06	5.71e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—INS—atherosclerosis	7e-06	5.69e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PPARG—atherosclerosis	6.97e-06	5.68e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—INS—atherosclerosis	6.97e-06	5.67e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTGS2—atherosclerosis	6.96e-06	5.66e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	6.94e-06	5.65e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—APOE—atherosclerosis	6.93e-06	5.64e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NOS3—atherosclerosis	6.93e-06	5.64e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSTM1—atherosclerosis	6.92e-06	5.63e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MMP9—atherosclerosis	6.89e-06	5.61e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CAV1—atherosclerosis	6.87e-06	5.59e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—INS—atherosclerosis	6.86e-06	5.58e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTM1—atherosclerosis	6.86e-06	5.58e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCL2—atherosclerosis	6.86e-06	5.58e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—APOA1—atherosclerosis	6.85e-06	5.58e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—INS—atherosclerosis	6.84e-06	5.57e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—NFKB1—atherosclerosis	6.82e-06	5.55e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—LPL—atherosclerosis	6.79e-06	5.53e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCL2—atherosclerosis	6.75e-06	5.49e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IGF1—atherosclerosis	6.74e-06	5.49e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—LPL—atherosclerosis	6.73e-06	5.48e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.72e-06	5.47e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK8—atherosclerosis	6.7e-06	5.45e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—AKT1—atherosclerosis	6.68e-06	5.44e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—MTHFR—atherosclerosis	6.65e-06	5.41e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF1—atherosclerosis	6.64e-06	5.4e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GPX1—atherosclerosis	6.63e-06	5.39e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GPX1—atherosclerosis	6.57e-06	5.35e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PPARA—atherosclerosis	6.52e-06	5.31e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CD36—atherosclerosis	6.45e-06	5.25e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—ALB—atherosclerosis	6.42e-06	5.22e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	6.4e-06	5.21e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CD36—atherosclerosis	6.4e-06	5.21e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.35e-06	5.17e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AGT—atherosclerosis	6.32e-06	5.14e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	6.3e-06	5.13e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—HMOX1—atherosclerosis	6.29e-06	5.12e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—ALB—atherosclerosis	6.27e-06	5.1e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CG—atherosclerosis	6.26e-06	5.09e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—APOE—atherosclerosis	6.19e-06	5.04e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—atherosclerosis	6.19e-06	5.03e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	6.14e-06	5e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—NOS3—atherosclerosis	6.14e-06	4.99e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CAV1—atherosclerosis	6.13e-06	4.99e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—STAT3—atherosclerosis	6.13e-06	4.98e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—APOA1—atherosclerosis	6.12e-06	4.98e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.12e-06	4.98e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NOS3—atherosclerosis	6.11e-06	4.98e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—MTHFR—atherosclerosis	6.06e-06	4.93e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PPARG—atherosclerosis	6.04e-06	4.92e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—APOB—atherosclerosis	6.03e-06	4.9e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NOS3—atherosclerosis	6.02e-06	4.9e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PPARA—atherosclerosis	6e-06	4.88e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—NOS3—atherosclerosis	6e-06	4.88e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PPARA—atherosclerosis	5.95e-06	4.84e-05	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	5.94e-06	4.83e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—INS—atherosclerosis	5.92e-06	4.82e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTM1—atherosclerosis	5.86e-06	4.77e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK3—atherosclerosis	5.85e-06	4.76e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—IL6—atherosclerosis	5.84e-06	4.76e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AGT—atherosclerosis	5.81e-06	4.73e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AGT—atherosclerosis	5.76e-06	4.69e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—LPL—atherosclerosis	5.75e-06	4.68e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—APOE—atherosclerosis	5.69e-06	4.63e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TGFB1—atherosclerosis	5.68e-06	4.62e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.66e-06	4.61e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—APOE—atherosclerosis	5.64e-06	4.59e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CAV1—atherosclerosis	5.64e-06	4.59e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—APOA1—atherosclerosis	5.63e-06	4.58e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GPX1—atherosclerosis	5.61e-06	4.57e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTGS2—atherosclerosis	5.61e-06	4.57e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CAV1—atherosclerosis	5.59e-06	4.55e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CG—atherosclerosis	5.59e-06	4.55e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—APOA1—atherosclerosis	5.58e-06	4.54e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MMP9—atherosclerosis	5.56e-06	4.52e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	5.5e-06	4.48e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTGS2—atherosclerosis	5.49e-06	4.46e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CD36—atherosclerosis	5.47e-06	4.45e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ALB—atherosclerosis	5.43e-06	4.42e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CXCL8—atherosclerosis	5.42e-06	4.41e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	5.41e-06	4.4e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PPARG—atherosclerosis	5.39e-06	4.39e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	5.39e-06	4.39e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	5.34e-06	4.34e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—INS—atherosclerosis	5.29e-06	4.3e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	5.24e-06	4.26e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—NOS3—atherosclerosis	5.2e-06	4.23e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.18e-06	4.22e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—IL6—atherosclerosis	5.16e-06	4.2e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	5.15e-06	4.19e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.14e-06	4.18e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CG—atherosclerosis	5.09e-06	4.14e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PPARA—atherosclerosis	5.08e-06	4.14e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—IL6—atherosclerosis	5.07e-06	4.13e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	4.99e-06	4.06e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PPARG—atherosclerosis	4.96e-06	4.04e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—STAT3—atherosclerosis	4.94e-06	4.02e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AGT—atherosclerosis	4.92e-06	4.01e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PPARG—atherosclerosis	4.92e-06	4e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MMP9—atherosclerosis	4.91e-06	3.99e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—INS—atherosclerosis	4.86e-06	3.96e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.85e-06	3.95e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NFKB1—atherosclerosis	4.85e-06	3.95e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ALB—atherosclerosis	4.85e-06	3.95e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MMP9—atherosclerosis	4.83e-06	3.93e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—APOE—atherosclerosis	4.82e-06	3.92e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—INS—atherosclerosis	4.82e-06	3.92e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CAV1—atherosclerosis	4.78e-06	3.89e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	4.78e-06	3.89e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK8—atherosclerosis	4.77e-06	3.88e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—APOA1—atherosclerosis	4.77e-06	3.88e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—AKT1—atherosclerosis	4.76e-06	3.87e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTGS2—atherosclerosis	4.75e-06	3.87e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	4.72e-06	3.84e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	4.69e-06	3.82e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	4.68e-06	3.81e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—APOB—atherosclerosis	4.65e-06	3.78e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—NOS3—atherosclerosis	4.64e-06	3.77e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	4.58e-06	3.73e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.52e-06	3.68e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ALB—atherosclerosis	4.46e-06	3.63e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—LPL—atherosclerosis	4.44e-06	3.61e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ALB—atherosclerosis	4.42e-06	3.6e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—atherosclerosis	4.4e-06	3.58e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—STAT3—atherosclerosis	4.36e-06	3.55e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.35e-06	3.54e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	4.33e-06	3.53e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GPX1—atherosclerosis	4.33e-06	3.53e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—STAT3—atherosclerosis	4.29e-06	3.49e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IL6—atherosclerosis	4.28e-06	3.48e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—NOS3—atherosclerosis	4.26e-06	3.47e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTGS2—atherosclerosis	4.24e-06	3.45e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—NOS3—atherosclerosis	4.23e-06	3.44e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CD36—atherosclerosis	4.22e-06	3.43e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PPARG—atherosclerosis	4.2e-06	3.42e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK3—atherosclerosis	4.17e-06	3.39e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—INS—atherosclerosis	4.12e-06	3.35e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	4.1e-06	3.34e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TGFB1—atherosclerosis	4.04e-06	3.29e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—MTHFR—atherosclerosis	4e-06	3.25e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	3.98e-06	3.24e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—AKT1—atherosclerosis	3.95e-06	3.21e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PPARA—atherosclerosis	3.92e-06	3.19e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.9e-06	3.17e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.87e-06	3.15e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—AKT1—atherosclerosis	3.81e-06	3.1e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AGT—atherosclerosis	3.8e-06	3.09e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ALB—atherosclerosis	3.78e-06	3.07e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—APOE—atherosclerosis	3.72e-06	3.03e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CAV1—atherosclerosis	3.69e-06	3e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—APOA1—atherosclerosis	3.68e-06	2.99e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—NOS3—atherosclerosis	3.61e-06	2.94e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—AKT1—atherosclerosis	3.5e-06	2.85e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL6—atherosclerosis	3.45e-06	2.81e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.36e-06	2.73e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.3e-06	2.69e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PPARG—atherosclerosis	3.24e-06	2.64e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—AKT1—atherosclerosis	3.18e-06	2.59e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—INS—atherosclerosis	3.18e-06	2.59e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL6—atherosclerosis	3.05e-06	2.48e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL6—atherosclerosis	3e-06	2.44e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ALB—atherosclerosis	2.92e-06	2.37e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—AKT1—atherosclerosis	2.82e-06	2.3e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—AKT1—atherosclerosis	2.81e-06	2.29e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NOS3—atherosclerosis	2.79e-06	2.27e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AKT1—atherosclerosis	2.77e-06	2.25e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—AKT1—atherosclerosis	2.76e-06	2.24e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.55e-06	2.08e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AKT1—atherosclerosis	2.39e-06	1.94e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AKT1—atherosclerosis	2.13e-06	1.73e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKT1—atherosclerosis	1.96e-06	1.6e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKT1—atherosclerosis	1.94e-06	1.58e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKT1—atherosclerosis	1.66e-06	1.35e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKT1—atherosclerosis	1.28e-06	1.04e-05	CbGpPWpGaD
